Beyond Air (XAIR) Competitors

$0.40 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$0.40 0.00 (0.00%)

As of 05/22/2026 07:45 PM Eastern

XAIR vs. TMDIF, FEMY, RVP, OSRH, and ICCM

Should you buy Beyond Air stock or one of its competitors? MarketBeat compares Beyond Air with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beyond Air include Titan Medical (TMDIF), Femasys (FEMY), Retractable Technologies (RVP), OSR (OSRH), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry.

How does Beyond Air compare to Titan Medical?

Beyond Air (NASDAQ:XAIR) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Beyond Air has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Beyond Air's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Beyond Air	Neutral
Titan Medical	Neutral

Beyond Air presently has a consensus price target of $10.00, suggesting a potential upside of 2,393.77%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -447.75%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
Titan Medical	N/A	-82.31%	-51.47%

Titan Medical has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A
Titan Medical	$17.63M	1.32	$6.95M	$0.05	4.08

Summary

Beyond Air and Titan Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Beyond Air compare to Femasys?

Beyond Air (NASDAQ:XAIR) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Beyond Air has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Femasys has a beta of -2.26, indicating that its share price is 326% less volatile than the broader market.

In the previous week, Femasys had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for Femasys and 0 mentions for Beyond Air. Beyond Air's average media sentiment score of 0.00 equaled Femasys'average media sentiment score.

Company	Overall Sentiment
Beyond Air	Neutral
Femasys	Neutral

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 10.0% of Beyond Air shares are held by company insiders. Comparatively, 7.6% of Femasys shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Beyond Air has a net margin of -447.75% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
Femasys	-521.97%	-258.08%	-73.72%

Femasys has lower revenue, but higher earnings than Beyond Air. Femasys is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A
Femasys	$2.29M	11.55	-$18.63M	-$0.27	N/A

Beyond Air presently has a consensus target price of $10.00, suggesting a potential upside of 2,393.77%. Femasys has a consensus target price of $5.33, suggesting a potential upside of 1,117.66%. Given Beyond Air's higher probable upside, analysts plainly believe Beyond Air is more favorable than Femasys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Femasys beats Beyond Air on 9 of the 15 factors compared between the two stocks.

How does Beyond Air compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

In the previous week, Beyond Air's average media sentiment score of 0.00 beat Retractable Technologies' score of -1.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Negative
Beyond Air	Neutral

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Retractable Technologies has a net margin of -41.11% compared to Beyond Air's net margin of -447.75%. Retractable Technologies' return on equity of -17.15% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Beyond Air	-447.75%	-268.82%	-98.49%

Retractable Technologies has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market. Comparatively, Beyond Air has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

Beyond Air has a consensus price target of $10.00, indicating a potential upside of 2,393.77%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Retractable Technologies has higher revenue and earnings than Beyond Air. Retractable Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A

Summary

Retractable Technologies beats Beyond Air on 8 of the 15 factors compared between the two stocks.

How does Beyond Air compare to OSR?

Beyond Air (NASDAQ:XAIR) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 10.0% of Beyond Air shares are held by insiders. Comparatively, 60.6% of OSR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

OSR has a net margin of -363.26% compared to Beyond Air's net margin of -447.75%. OSR's return on equity of -7.24% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
OSR	-363.26%	-7.24%	-5.41%

Beyond Air has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market. Comparatively, OSR has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

Beyond Air currently has a consensus price target of $10.00, suggesting a potential upside of 2,393.77%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

OSR has lower revenue, but higher earnings than Beyond Air. OSR is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A
OSR	$2.91M	6.06	-$27.06M	-$0.33	N/A

In the previous week, Beyond Air's average media sentiment score of 0.00 equaled OSR'saverage media sentiment score.

Company	Overall Sentiment
Beyond Air	Neutral
OSR	Neutral

Summary

OSR beats Beyond Air on 9 of the 14 factors compared between the two stocks.

How does Beyond Air compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

IceCure Medical has higher earnings, but lower revenue than Beyond Air. IceCure Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A

IceCure Medical has a net margin of -441.60% compared to Beyond Air's net margin of -447.75%. IceCure Medical's return on equity of -211.73% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
Beyond Air	-447.75%	-268.82%	-98.49%

IceCure Medical has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 10.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

IceCure Medical presently has a consensus target price of $2.09, suggesting a potential upside of 789.36%. Beyond Air has a consensus target price of $10.00, suggesting a potential upside of 2,393.77%. Given Beyond Air's higher probable upside, analysts clearly believe Beyond Air is more favorable than IceCure Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, IceCure Medical had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for IceCure Medical and 0 mentions for Beyond Air. IceCure Medical's average media sentiment score of 0.61 beat Beyond Air's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company	Overall Sentiment
IceCure Medical	Positive
Beyond Air	Neutral

Summary

IceCure Medical beats Beyond Air on 10 of the 16 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.29M	$3.37B	$6.46B	$12.34B
Dividend Yield	N/A	2.26%	2.76%	5.28%
P/E Ratio	-0.07	18.74	21.00	25.66
Price / Sales	1.43	323.98	562.18	86.31
Price / Cash	N/A	125.17	43.49	56.67
Price / Book	0.12	7.09	10.41	7.14
Net Income	-$46.62M	$24.45M	$3.57B	$335.98M
7 Day Performance	-7.00%	6.38%	6.40%	4.11%
1 Month Performance	-21.37%	2.43%	3.54%	2.52%
1 Year Performance	-89.45%	62.98%	34.14%	35.04%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	2.1724 of 5 stars	$0.40 flat	$10.00 +2,393.8%	-89.4%	$5.29M	$3.70M	N/A	70	Gap Up
TMDIF Titan Medical	N/A	$0.20 -10.3%	N/A	-26.0%	$22.92M	$17.63M	N/A	50	Gap Down
FEMY Femasys	2.1398 of 5 stars	$0.36 -1.2%	$5.33 +1,387.3%	-57.9%	$21.91M	$2.29M	N/A	30	Gap Down
RVP Retractable Technologies	N/A	$0.68 +1.6%	N/A	+9.9%	$20.39M	$38.27M	N/A	240	Negative News Gap Down
OSRH OSR	0.4728 of 5 stars	$0.51 -2.4%	N/A	-56.7%	$18.35M	$2.91M	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. TMDIF, FEMY, RVP, OSRH, and ICCM

How does Beyond Air compare to Titan Medical?

Summary

How does Beyond Air compare to Femasys?

Summary

How does Beyond Air compare to Retractable Technologies?

Summary

How does Beyond Air compare to OSR?

Summary

How does Beyond Air compare to IceCure Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. TMDIF, FEMY, RVP, OSRH, and ICCM

How does Beyond Air compare to Titan Medical?

Which has more volatility and risk, XAIR or TMDIF?

Do insiders and institutionals have more ownership in XAIR or TMDIF?

Does the media favor XAIR or TMDIF?

Do analysts recommend XAIR or TMDIF?

Is XAIR or TMDIF more profitable?

Which has preferable earnings and valuation, XAIR or TMDIF?

Summary

How does Beyond Air compare to Femasys?

Which has more risk & volatility, XAIR or FEMY?

Does the media favor XAIR or FEMY?

Do institutionals and insiders believe in XAIR or FEMY?

Is XAIR or FEMY more profitable?

Which has better earnings & valuation, XAIR or FEMY?

Do analysts rate XAIR or FEMY?

Summary

How does Beyond Air compare to Retractable Technologies?

Does the media refer more to RVP or XAIR?

Do insiders & institutionals hold more shares of RVP or XAIR?

Is RVP or XAIR more profitable?

Which has more volatility and risk, RVP or XAIR?

Do analysts prefer RVP or XAIR?

Which has stronger valuation and earnings, RVP or XAIR?

Summary

How does Beyond Air compare to OSR?

Do institutionals & insiders hold more shares of XAIR or OSRH?

Is XAIR or OSRH more profitable?

Which has more risk and volatility, XAIR or OSRH?

Do analysts prefer XAIR or OSRH?

Which has higher valuation & earnings, XAIR or OSRH?

Does the media refer more to XAIR or OSRH?

Summary

How does Beyond Air compare to IceCure Medical?

Which has better valuation & earnings, ICCM or XAIR?

Is ICCM or XAIR more profitable?

Which has more volatility & risk, ICCM or XAIR?

Do insiders & institutionals believe in ICCM or XAIR?

Do analysts recommend ICCM or XAIR?

Does the media refer more to ICCM or XAIR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools